id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0039-0091,FDA,FDA-2008-N-0039,Ophthalmic and Topical Dosage Form New Animal Drugs; Triamcinolone Cream,Rule,Final Rule,2008-12-29T05:00:00Z,2008,12,2008-12-29T05:00:00Z,,2013-07-09T18:48:19Z,E8-30694,0,0,0900006480805eeb
FDA-2008-S-0350-0001,FDA,FDA-2008-S-0350,Food Additives Permitted in Feed and Drinking Water of Animals,Rule,NCR-Notice of Correction,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2008-12-24T17:44:31Z,E8-30840,0,0,09000064807f8dc4
FDA-2000-N-0011-0004,FDA,FDA-2000-N-0011,"Uniform Compliance Date for Food Labeling Regulations, January 2, 2012",Rule,NFR-Notice of Final Rule,2008-12-08T05:00:00Z,2008,12,2008-12-08T05:00:00Z,2009-02-24T04:59:59Z,2009-01-08T16:17:38Z,E8-28920,0,0,09000064807d2029
FDA-2008-N-0039-0082,FDA,FDA-2008-N-0039,New Animal Drugs; Ractopamine,Rule,Final Rule,2008-12-01T05:00:00Z,2008,12,2008-12-01T05:00:00Z,,2013-07-10T16:15:59Z,E8-28384,0,0,09000064807c7111
FDA-2008-N-0326-0176,FDA,FDA-2008-N-0326,New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Revocation of Order of Prohibition; Withdrawal,Rule,NWL-Notice of Withdrawl,2008-11-26T05:00:00Z,2008,11,2008-11-26T05:00:00Z,,2008-12-20T16:26:21Z,E8-28093,0,0,09000064807c1087
FDA-2008-N-0039-0081,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Amprolium; Correction,Rule,Correction,2008-11-20T05:00:00Z,2008,11,2008-11-20T05:00:00Z,,2013-07-11T14:19:15Z,E8-27646,0,0,09000064807b36b5
FDA-2007-N-0314-0044,FDA,FDA-2007-N-0314,Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule,Rule,NFR-Notice of Final Rule,2008-11-19T05:00:00Z,2008,11,2008-11-19T05:00:00Z,,2011-06-11T16:26:51Z,E8-27436,0,0,09000064807b155a
FDA-2006-N-0364-0007,FDA,FDA-2006-N-0364,Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile; Technical Amendment,Rule,Final Rule,2008-11-18T05:00:00Z,2008,11,2008-11-18T05:00:00Z,,2015-11-12T18:01:15Z,E8-27254,0,0,09000064807af926
FDA-2008-N-0561-0002,FDA,FDA-2008-N-0561,Maximum Civil Money Penalty Amounts and Compliance with the Federal Civil Penalties Inflation Adjustment Act,Rule,NFR-Notice of Final Rule,2008-11-12T05:00:00Z,2008,11,2008-11-12T05:00:00Z,2009-01-27T04:59:59Z,2009-01-22T18:45:33Z,E8-26866,0,0,09000064807a4dd5
FDA-2004-N-0511-0005,FDA,FDA-2004-N-0511,Obstetrical and Gynecological Devices; Designation of Special Controls for Male Condoms Made of Natural Rubber Latex,Rule,Final Rule,2008-11-10T05:00:00Z,2008,11,2008-11-10T05:00:00Z,,2016-03-04T16:13:54Z,E8-26825,0,0,09000064807a13e7
FDA-2002-N-0233-0212,FDA,FDA-2002-N-0233,Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Availability,Rule,NFR-Notice of Final Rule,2008-11-07T05:00:00Z,2008,11,,,2011-06-11T16:25:54Z,E8-26282,0,0,090000648079c41b
FDA-2008-N-0039-0077,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Firocoxib Tablets,Rule,Final Rule,2008-10-31T04:00:00Z,2008,10,,,2013-07-10T18:54:17Z,E8-26020,0,0,090000648078769c
FDA-2003-F-0398-0002,FDA,FDA-2003-F-0398,"Food Additives Permitted in Feed and Drinking Water of Animals; Methyl Esters of Conjugated Linoleic Acid (Cis-9, Trans-11 and Trans- 10, Cis-12-Octadecadienoic Acids)",Rule,NFR-Notice of Final Rule,2008-10-29T04:00:00Z,2008,10,2008-10-29T04:00:00Z,2008-12-30T04:59:59Z,2008-12-29T12:14:30Z,E8-25719,0,0,0900006480782b85
FDA-2003-N-0313-0008,FDA,FDA-2003-N-0313,Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products; Final Rule,Rule,Final Rule,2008-10-28T04:00:00Z,2008,10,2008-10-28T04:00:00Z,,2016-02-09T17:49:24Z,E8-25670,0,0,0900006480780764
FDA-2002-N-0031-0130,FDA,FDA-2002-N-0031,Substances Prohibited From Use in Animal Food or Feed; Correction,Rule,NCR-Notice of Correction,2008-10-23T04:00:00Z,2008,10,,,2011-06-11T16:25:52Z,E8-25346,0,0,090000648077424d
FDA-1985-P-0452-0009,FDA,FDA-1985-P-0452,Medical Devices; Reclassification of the Automated Heparin Analyzer,Rule,NFR-Notice of Final Rule,2008-10-12T04:00:00Z,2008,10,2008-10-12T04:00:00Z,,2008-10-12T18:23:02Z,,0,0,09000064805b76eb
FDA-1978-N-1980-0002,FDA,FDA-1978-N-1980,Hematology and Pathology Devices; Classification of Heparin Assays,Rule,NFR-Notice of Final Rule,2008-10-12T04:00:00Z,2008,10,2008-10-12T04:00:00Z,1980-10-15T03:59:59Z,2008-10-12T19:10:36Z,,0,0,09000064805a1af8
FDA-2008-N-0039-0071,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin,Rule,Final Rule,2008-10-08T04:00:00Z,2008,10,2008-10-08T04:00:00Z,,2013-07-10T18:24:50Z,E8-23832,0,0,090000648073e0bc
FDA-2008-N-0148-0004,FDA,FDA-2008-N-0148,Medical Devices; Hearing Aids; Technical Data Amendments; Confirmation of Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2008-10-08T04:00:00Z,2008,10,2008-10-08T04:00:00Z,,2008-10-08T13:24:08Z,E8-23717,0,0,090000648073e1b1
FDA-2008-N-0039-0075,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid,Rule,Final Rule,2008-10-08T04:00:00Z,2008,10,2008-10-08T04:00:00Z,,2013-07-10T19:01:42Z,E8-23830,0,0,090000648073e103
FDA-2008-N-0039-0073,FDA,FDA-2008-N-0039,New Animal Drugs for Use in Animal Feeds; Fenbendazole,Rule,Final Rule,2008-10-08T04:00:00Z,2008,10,2008-10-08T04:00:00Z,,2013-07-10T20:10:36Z,E8-23845,0,0,090000648073e0ff
FDA-1978-N-0630-0002,FDA,FDA-1978-N-0630,Hematology and Pathology Devices Classification of Automated Heparin Analyzers,Rule,NFR-Notice of Final Rule,2008-10-01T04:00:00Z,2008,10,2008-10-01T04:00:00Z,1980-10-15T03:59:59Z,2008-10-02T00:26:56Z,,0,0,0900006480578f48
FDA-2008-N-0341-0001,FDA,FDA-2008-N-0341,Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs,Rule,NFR-Notice of Final Rule,2008-09-29T04:00:00Z,2008,9,2008-09-29T04:00:00Z,2008-12-16T04:59:59Z,2009-02-06T16:52:46Z,E8-22833,0,0,090000648072c51b
FDA-2004-P-0205-0006,FDA,FDA-2004-P-0205,"Food Labeling: Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis",Rule,NFR-Notice of Final Rule,2008-09-29T04:00:00Z,2008,9,2008-09-29T04:00:00Z,,2008-09-29T12:17:32Z,E8-22730,0,0,090000648072c5fe
FDA-2008-N-0423-0002,FDA,FDA-2008-N-0423,FDA Regulations; Technical Amendment; Correction,Rule,NCR-Notice of Correction,2008-09-19T04:00:00Z,2008,9,,,2008-09-19T12:16:15Z,E8-21966,0,0,090000648070f519
FDA-2008-N-0310-0004,FDA,FDA-2008-N-0310,Medical Devices; Medical Device Reporting; Baseline Reports; Confirmationof Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2008-09-17T04:00:00Z,2008,9,2008-09-17T04:00:00Z,,2008-09-17T14:00:36Z,E8-21756,0,0,090000648070a66c
FDA-2008-N-0039-0070,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Sulfadiazine/Pyrimethamine Suspension,Rule,Final Rule,2008-09-17T04:00:00Z,2008,9,2008-09-17T04:00:00Z,,2013-07-10T18:41:20Z,E8-21625,0,0,090000648070a75b
FDA-2003-N-0427-0093,FDA,FDA-2003-N-0427,"Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals",Rule,NFR-Notice of Final Rule,2008-09-08T04:00:00Z,2008,9,2008-09-08T04:00:00Z,,2008-09-08T12:08:38Z,E8-20779,0,0,09000064806f82c7
FDA-2007-N-0379-0007,FDA,FDA-2007-N-0379,Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals,Rule,Final Rule,2008-09-08T04:00:00Z,2008,9,,,2025-07-28T22:46:26Z,E8-20709,0,0,09000064806f8324
FDA-1999-F-2405-0005,FDA,FDA-1999-F-2405,"Irradiation in the Production, Processing and Handling of Food",Rule,NFR-Notice of Final Rule,2008-08-22T04:00:00Z,2008,8,2008-08-22T04:00:00Z,2008-09-23T03:59:59Z,2015-09-17T01:30:21Z,E8-19573,0,0,09000064806d2f95
FDA-2008-N-0032-0031,FDA,FDA-2008-N-0032,"Supplemental Applications Proposing Labeling Changes for Approved Drugs, Biologics, and Medical Devices",Rule,NFR-Notice of Final Rule,2008-08-22T04:00:00Z,2008,8,,,2011-06-11T16:27:11Z,E8-19572,0,0,09000064806d303d
FDA-2008-N-0326-0049,FDA,FDA-2008-N-0326,New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition; Extension of Comment Period; Delay of Effective Date of Final Rule,Rule,Delay of Effective Date,2008-08-18T04:00:00Z,2008,8,2008-08-18T04:00:00Z,2008-11-04T04:59:59Z,2012-01-27T23:43:15Z,E8-18967,0,0,09000064806ca625
FDA-2008-N-0039-0064,FDA,FDA-2008-N-0039,New Animal Drugs For Use in Animal Feeds; Oxytetracycline,Rule,Final Rule,2008-08-07T04:00:00Z,2008,8,,,2013-07-11T13:44:20Z,E8-18129,0,0,09000064806b4074
FDA-2008-N-0039-0060,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Amprolium,Rule,Final Rule,2008-08-06T04:00:00Z,2008,8,2008-08-06T04:00:00Z,,2013-07-11T14:22:57Z,E8-18093,0,0,09000064806b15a2
FDA-2008-N-0039-0061,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Oxfendazole Suspension,Rule,Final Rule,2008-08-06T04:00:00Z,2008,8,2008-08-06T04:00:00Z,,2013-07-10T19:50:02Z,E8-18092,0,0,09000064806b161e
FDA-2008-N-0039-0062,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride,Rule,Final Rule,2008-08-06T04:00:00Z,2008,8,2008-08-06T04:00:00Z,,2013-07-10T16:28:17Z,E8-18094,0,0,09000064806b166e
FDA-2005-N-0170-0005,FDA,FDA-2005-N-0170,Current Good Manufacturing Practice and Investigational New Drugs Intended for Use in Clinical Trials; Final Rule,Rule,Final Rule,2008-07-15T04:00:00Z,2008,7,2008-07-15T04:00:00Z,,2024-11-12T04:18:20Z,E8-16011,1,0,090000648067534f
FDA-2008-N-0326-0001,FDA,FDA-2008-N-0326,New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition,Rule,NFR-Notice of Final Rule,2008-07-03T04:00:00Z,2008,7,2008-07-03T04:00:00Z,2008-09-04T03:59:59Z,2012-07-05T02:02:01Z,E8-15052,0,0,0900006480653961
FDA-2008-N-0039-0059,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Sulfachlorpyridazine Powder,Rule,Final Rule,2008-06-24T04:00:00Z,2008,6,2008-06-24T04:00:00Z,,2013-07-11T14:16:03Z,E8-14291,0,0,0900006480639a99
FDA-2008-N-0039-0058,FDA,FDA-2008-N-0039,New Animal Drugs; Change of Sponsors Drug Labeler Code,Rule,Final Rule,2008-06-23T04:00:00Z,2008,6,2008-06-23T04:00:00Z,,2013-07-11T14:33:23Z,E8-14149,0,0,090000648063712a
FDA-2008-N-0331-0001,FDA,FDA-2008-N-0331,Medical Devices; Change of Name; Technical Amendment,Rule,NFR-Notice of Final Rule,2008-06-23T04:00:00Z,2008,6,2008-06-23T04:00:00Z,,2008-06-23T12:17:39Z,E8-14153,0,0,0900006480637136
FDA-2006-N-0364-0003,FDA,FDA-2006-N-0364,Final Rule Exceptions or Alternatives to Labeling Requirements for Products,Rule,Final Rule,2008-06-18T04:00:00Z,2008,6,2008-06-18T04:00:00Z,,2015-11-12T19:37:29Z,E7-25165,0,0,090000648062d5ec
FDA-2008-N-0039-0055,FDA,FDA-2008-N-0039,New Animal Drugs For Use in Animal Feeds; Tylosin,Rule,Final Rule,2008-06-17T04:00:00Z,2008,6,2008-06-17T04:00:00Z,,2013-07-10T18:02:55Z,E8-13606,0,0,090000648062a67e
FDA-2008-N-0039-0056,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Ivermectin Paste,Rule,Final Rule,2008-06-17T04:00:00Z,2008,6,2008-06-17T04:00:00Z,,2013-07-10T15:21:43Z,E8-13607,0,0,090000648062a642
FDA-2008-N-0039-0053,FDA,FDA-2008-N-0039,"Oral Dosage Form New Animal Drugs; Ivermectin, Fenbendazole, and Praziquantel Tablets",Rule,Final Rule,2008-06-13T04:00:00Z,2008,6,,,2013-07-10T16:34:56Z,E8-13354,0,0,0900006480623e54
FDA-2008-N-0039-0051,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Deracoxib,Rule,Final Rule,2008-06-13T04:00:00Z,2008,6,,,2013-07-10T19:07:16Z,E8-13353,0,0,0900006480623d7e
FDA-2008-N-0039-0049,FDA,FDA-2008-N-0039,Notice of Approval of Supplemental New Animal Drug Application; Moxidectin,Rule,Approval,2008-06-09T04:00:00Z,2008,6,2008-06-09T04:00:00Z,,2013-07-10T19:13:32Z,08-01329,0,0,0900006480619532
FDA-2008-N-0039-0047,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Butorphanol,Rule,Final Rule,2008-06-02T04:00:00Z,2008,6,2008-06-02T04:00:00Z,,2013-07-10T15:16:42Z,E8-12160,0,0,090000648060bd12
FDA-2008-N-0148-0001,FDA,FDA-2008-N-0148,Medical Devices; Hearing Aids; Technical Data Amendments,Rule,NFR-Notice of Final Rule,2008-06-02T04:00:00Z,2008,6,2008-06-02T04:00:00Z,2008-08-19T03:59:59Z,2008-08-18T11:10:15Z,E8-11910,0,0,090000648060bd39
FDA-2006-P-0404-0004,FDA,FDA-2006-P-0404,Food Labeling: Health Claims; Dietary Noncariogenic Carbohydrate Sweeteners and Dental Caries,Rule,NFR-Notice of Final Rule,2008-05-27T04:00:00Z,2008,5,2008-05-27T04:00:00Z,,2008-05-27T12:02:15Z,E8-11802,0,0,0900006480600f81
FDA-2008-N-0039-0045,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Cefovecin,Rule,Final Rule,2008-05-22T04:00:00Z,2008,5,2008-05-22T04:00:00Z,,2013-07-09T20:04:25Z,E8-11515,0,0,09000064805f84e3
FDA-2008-N-0231-0001,FDA,FDA-2008-N-0231,Medical Devices; Immunology and Microbiology Devices; Classification of Plasmodium Species Antigen Detection Assays,Rule,NFR-Notice of Final Rule,2008-05-20T04:00:00Z,2008,5,2008-05-20T04:00:00Z,,2008-05-20T12:51:57Z,E8-11263,0,0,09000064805f479e
FDA-2008-N-0039-0043,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Flunixin,Rule,Final Rule,2008-05-15T04:00:00Z,2008,5,2008-05-15T04:00:00Z,,2013-07-10T15:59:09Z,E8-10856,0,0,09000064805c7f71
FDA-2008-N-0152-0002,FDA,FDA-2008-N-0152,"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Technical Amendment",Rule,NFR-Notice of Final Rule,2008-05-14T04:00:00Z,2008,5,2008-05-14T04:00:00Z,,2011-06-11T16:27:41Z,E8-10727,0,0,09000064805b7e07
FDA-2008-N-0039-0041,FDA,FDA-2008-N-0039,Certain Other Dosage Form New Animal Drugs; Sevoflurane,Rule,Final Rule,2008-05-07T04:00:00Z,2008,5,,,2013-07-09T18:52:23Z,E8-10153,0,0,090000648054eee0
FDA-2008-N-0039-0042,FDA,FDA-2008-N-0039,Sevoflurane; Freedom of Information Summary,Rule,Final Rule,2008-05-07T04:00:00Z,2008,5,2008-05-07T04:00:00Z,,2013-07-09T18:53:51Z,,0,0,090000648054f250
FDA-2006-P-0405-0011,FDA,FDA-2006-P-0405,Food Labeling: Health Claims; Soluble Fiber from Certain Foods and Risk of Coronary Heart Disease,Rule,NFR-Notice of Final Rule,2008-05-01T04:00:00Z,2008,5,,,2008-05-01T21:45:54Z,E8-09590,0,0,090000648053f6ca
FDA-2008-N-0039-0040,FDA,FDA-2008-N-0039,New Animal Drugs; Change of Sponsors Name,Rule,Final Rule,2008-04-29T04:00:00Z,2008,4,,,2013-07-11T14:34:22Z,E8-09328,0,0,0900006480539f86
FDA-2004-N-0061-0002,FDA,FDA-2004-N-0061,Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application; Final Rule,Rule,Final Rule,2008-04-28T04:00:00Z,2008,4,2008-04-28T04:00:00Z,,2016-02-04T16:49:48Z,E8-09200,0,0,0900006480537f08
FDA-2002-N-0031-0110,FDA,FDA-2002-N-0031,Substances Prohibited From Use in Animal Food or Feed,Rule,NFR-Notice of Final Rule,2008-04-25T04:00:00Z,2008,4,,,2011-06-11T16:25:53Z,08-01180,0,0,0900006480532ba5
FDA-2008-N-0039-0036,FDA,FDA-2008-N-0039,New Animal Drugs; Enrofloxacin Final Rule,Rule,Final Rule,2008-04-23T04:00:00Z,2008,4,,,2013-07-10T19:23:29Z,E8-08713,0,0,090000648052275b
FDA-2008-N-0039-0035,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Insulin,Rule,Final Rule,2008-04-18T04:00:00Z,2008,4,,,2013-07-10T18:42:50Z,E8-08347,0,0,0900006480511b3a
FDA-2008-N-0039-0034,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol,Rule,Final Rule,2008-04-18T04:00:00Z,2008,4,,,2013-07-10T19:52:36Z,E8-08346,0,0,0900006480511af1
FDA-2004-N-0188-0034,FDA,FDA-2004-N-0188,Use of Materials Derived From Cattle in Human Food and Cosmetics - Interim Final Rule and Request for Comments,Rule,NIR-Notice of Interim Rule,2008-04-17T04:00:00Z,2008,4,2008-04-17T04:00:00Z,2008-07-17T03:59:59Z,2011-06-11T16:25:55Z,08-01142,0,0,090000648050c23c
FDA-2008-N-0039-0032,FDA,FDA-2008-N-0039,New Animal Drugs For Use in Animal Feed; Zilpaterol,Rule,Final Rule,2008-04-10T04:00:00Z,2008,4,,,2013-07-10T17:18:08Z,E8-07583,0,0,09000064804a32eb
FDA-2007-N-0379-0004,FDA,FDA-2007-N-0379,Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Withdrawal,Rule,Withdrawal,2008-04-08T04:00:00Z,2008,4,,,2025-07-28T22:41:09Z,E8–7107,0,0,0900006480472f5c
FDA-2008-N-0039-0030,FDA,FDA-2008-N-0039,New Animal Drugs for Use in Animal Feed; Zilpaterol; Technical Amendment,Rule,NFR-Notice of Final Rule,2008-04-08T04:00:00Z,2008,4,2008-04-08T04:00:00Z,,2008-04-11T22:39:13Z,E8-07307,0,0,090000648046e47e
FDA-2008-N-0039-0029,FDA,FDA-2008-N-0039,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs; Technical Amendment",Rule,Final Rule,2008-04-04T04:00:00Z,2008,4,2008-04-04T04:00:00Z,,2013-07-11T14:36:14Z,E8-07103,0,0,0900006480439f88
FDA-2008-N-0179-0001,FDA,FDA-2008-N-0179,Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Withdrawal [Re: FDA-2007-N-0379],Rule,Withdrawal,2008-04-04T04:00:00Z,2008,4,2008-04-04T04:00:00Z,,2015-12-07T14:57:09Z,E8-07107,0,0,0900006480439f69
FDA-2008-N-0039-0026,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin,Rule,Final Rule,2008-04-02T04:00:00Z,2008,4,,,2013-07-10T19:26:20Z,E8-06706,0,0,0900006480427483
FDA-2008-N-0039-0025,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Benzathine and Penicillin G Procaine Suspension,Rule,Final Rule,2008-03-31T04:00:00Z,2008,3,,,2013-07-11T13:26:42Z,E8-06603,0,0,0900006480414884
FDA-2008-N-0039-0024,FDA,FDA-2008-N-0039,New Animal Drugs For Use in Animal Feed; Zilpaterol,Rule,NFR-Notice of Final Rule,2008-03-31T04:00:00Z,2008,3,,,2013-07-10T16:46:30Z,E8-06601,0,0,0900006480414833
FDA-2008-N-0042-0003,FDA,FDA-2008-N-0042,Civil Money Penalties Hearings; Maximum Penalty Amounts; Technical Amendment,Rule,NFR-Notice of Final Rule,2008-03-26T04:00:00Z,2008,3,,,2008-04-11T22:39:24Z,E8-06082,0,0,09000064804092ec
FDA-2008-N-0160-0001,FDA,FDA-2008-N-0160,Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Technical Amendment,Rule,NFR-Notice of Final Rule,2008-03-26T04:00:00Z,2008,3,,,2008-04-11T22:39:39Z,E8-06052,0,0,090000648040928e
FDA-2008-N-0039-0022,FDA,FDA-2008-N-0039,New Animal Drugs for Use in Animal Feeds; Bacitracin Methylene Disalicylate and Nicarbazin,Rule,Final Rule,2008-03-26T04:00:00Z,2008,3,,,2013-07-10T17:51:33Z,E8-06063,0,0,090000648040922b
FDA-2008-N-0042-0002,FDA,FDA-2008-N-0042,New Animal Drugs for Use in Animal Feed; Pyrantel; Technical Amendment,Rule,NFR-Notice of Final Rule,2008-03-25T04:00:00Z,2008,3,2008-03-25T04:00:00Z,,2008-04-11T22:39:23Z,E8-05928,0,0,090000648040797f
FDA-2008-N-0039-0021,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Solution,Rule,Final Rule,2008-03-20T04:00:00Z,2008,3,,,2013-07-10T19:19:30Z,E8-05598,0,0,0900006480400974
FDA-2008-N-0039-0019,FDA,FDA-2008-N-0039,New Animal Drugs for Use in Animal Feed; Zilpaterol,Rule,Final Rule,2008-03-18T04:00:00Z,2008,3,,,2013-07-10T17:55:05Z,E8-05450,0,0,09000064803fc2e6
FDA-2008-N-0039-0018,FDA,FDA-2008-N-0039,New Animal Drugs; Change of Sponsors Name; Iron Injection; Technical Amendment,Rule,Final Rule,2008-03-18T04:00:00Z,2008,3,,,2013-07-11T12:54:27Z,E8-05452,0,0,09000064803fc3f3
FDA-2008-N-0039-0017,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Procaine Aqueous Suspension,Rule,Final Rule,2008-03-17T04:00:00Z,2008,3,2008-03-17T04:00:00Z,,2013-07-11T13:42:23Z,E8-05217,0,0,09000064803faa5f
FDA-2008-N-0152-0001,FDA,FDA-2008-N-0152,"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Technical Amendment",Rule,NFR-Notice of Final Rule,2008-03-12T04:00:00Z,2008,3,,,2011-06-11T16:27:41Z,E8-04870,0,0,09000064803f25cf
FDA-2008-N-0039-0016,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide Injection; Gleptoferron Injection; Iron Dextran Complex Injection; Iron Hydrogenated Dextran Injection,Rule,Final Rule,2008-03-10T04:00:00Z,2008,3,2008-03-10T04:00:00Z,,2013-07-11T14:40:49Z,E8-04603,0,0,09000064803ef1ac
FDA-2008-N-0039-0015,FDA,FDA-2008-N-0039,Intramammary Dosage Forms; Cephapirin Benzathine,Rule,Final Rule,2008-03-07T05:00:00Z,2008,3,2008-03-07T05:00:00Z,,2013-07-11T12:48:12Z,E8-04473,0,0,09000064803eace5
FDA-2008-N-0135-0001,FDA,FDA-2008-N-0135,Revision of the Requirements for Live Vaccine Processing; Confirmation of Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2008-03-07T05:00:00Z,2008,3,2008-03-07T05:00:00Z,,2024-11-07T21:51:09Z,E8-04471,1,0,09000064803eac81
FDA-2008-N-0039-0013,FDA,FDA-2008-N-0039,New Animal Drugs; Albendazole,Rule,Final Rule,2008-02-29T05:00:00Z,2008,2,,,2013-07-11T12:43:54Z,E8-03877,0,0,09000064803d5031
FDA-2008-P-0090-0001,FDA,FDA-2008-P-0090,Food Labeling: Health Claims; Soluble Fiber From Certain Foods and Risk of Coronary Heart Disease,Rule,NIR-Notice of Interim Rule,2008-02-25T05:00:00Z,2008,2,2008-02-25T05:00:00Z,2008-05-13T03:59:59Z,2011-06-11T16:27:55Z,E8-03418,0,0,09000064803c32fb
FDA-2008-N-0039-0011,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Altrenogest,Rule,Final Rule,2008-02-21T05:00:00Z,2008,2,2008-02-21T05:00:00Z,,2013-07-11T12:41:07Z,E8-03265,0,0,09000064803b9f24
FDA-2008-N-0039-0010,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Ivermectin Liquid,Rule,NFR-Notice of Final Rule,2008-02-21T05:00:00Z,2008,2,2008-02-21T05:00:00Z,,2013-07-10T15:41:57Z,E8-03266,0,0,09000064803b9f98
FDA-2008-N-0068-0001,FDA,FDA-2008-N-0068,Generally Recognized As Safe Substances; Technical Amendments,Rule,ND-Notice of Denial,2008-02-14T05:00:00Z,2008,2,2008-02-14T05:00:00Z,,2008-11-17T22:43:38Z,E8-02809,0,0,09000064803ae9eb
FDA-2008-N-0039-0009,FDA,FDA-2008-N-0039,New Animal Drugs; Change of Sponsor; Ketamine,Rule,Final Rule,2008-02-13T05:00:00Z,2008,2,2008-02-13T05:00:00Z,,2013-07-10T16:07:12Z,E8-02607,0,0,09000064803adb81
FDA-2008-N-0039-0008,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets,Rule,Final Rule,2008-02-13T05:00:00Z,2008,2,2008-02-13T05:00:00Z,,2013-07-11T13:04:52Z,E8-02608,0,0,09000064803adadb
FDA-2008-N-0039-0007,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs: Spectinomycin,Rule,NFR-Notice of Final Rule,2008-02-05T05:00:00Z,2008,2,,,2008-04-11T22:39:13Z,E8-02065,0,0,09000064803a8563
FDA-2008-N-0075-0001,FDA,FDA-2008-N-0075,Skin Protectant Drug Products for Over-the-Counter Human Use; Reduced Labeling; Technical Amendment,Rule,NFR-Notice of Final Order,2008-02-01T05:00:00Z,2008,2,2008-02-01T05:00:00Z,,2011-06-11T16:27:38Z,E8-01818,0,0,09000064803a6435
FDA-2008-N-0039-0005,FDA,FDA-2008-N-0039,Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin,Rule,Final Rule,2008-02-01T05:00:00Z,2008,2,2008-02-01T05:00:00Z,,2013-07-10T18:34:59Z,E8-01906,0,0,09000064803a6488
FDA-2008-N-0039-0003,FDA,FDA-2008-N-0039,New Animal Drugs For Use in Animal Feed; Zilpaterol,Rule,Final Rule,2008-02-01T05:00:00Z,2008,2,2008-02-01T05:00:00Z,,2013-07-11T14:38:03Z,E8-01903,0,0,09000064803a642e
FDA-2008-N-0039-0002,FDA,FDA-2008-N-0039,Oral Dosage Form New Animal Drugs; Clindamycin,Rule,Final Rule,2008-01-24T05:00:00Z,2008,1,2008-01-24T05:00:00Z,,2013-07-09T20:13:31Z,E8-01199,0,0,09000064803a17e1
FDA-2008-N-0042-0001,FDA,FDA-2008-N-0042,"Human Cells, Tissues, and Cellular and Tissue-Based Products",Rule,NFR-Notice of Final Rule,2008-01-18T05:00:00Z,2008,1,2008-01-18T05:00:00Z,,2008-11-17T19:37:28Z,08-55500,0,0,090000648039d570
FDA-2008-N-0039-0001,FDA,FDA-2008-N-0039,Intramammary Dosage Forms; Cephapirin Sodium,Rule,Final Rule,2008-01-17T05:00:00Z,2008,1,2008-01-17T05:00:00Z,,2013-07-11T13:00:09Z,E8-00816,0,0,090000648039c6a6
FDA-2008-N-0034-0001,FDA,FDA-2008-N-0034,Oral Dosage Form New Animal Drugs; Firocoxib Tablets,Rule,NFR-Notice of Final Rule,2008-01-16T05:00:00Z,2008,1,2008-01-16T05:00:00Z,,2008-11-21T21:01:33Z,E8-00730,0,0,090000648039b8a9
FDA-2008-N-0035-0001,FDA,FDA-2008-N-0035,Implantation or Injectable Dosage Form New Animal Drugs; Flunixin,Rule,NFR-Notice of Final Rule,2008-01-16T05:00:00Z,2008,1,2008-01-16T05:00:00Z,,2008-11-21T21:53:25Z,E8-00699,0,0,090000648039b8bd